Transient suppression of the ECM1 gatekeeper is essential for HGF/c-MET-driven liver regeneration
Yao, Y.; Li, Y.; Huang, C.; Ma, J.; Xu, L.; Wolf, S. D.; Gilljam, J.; Zeng, H.; Munker, S.; Cao-Ehlker, X.; Li, R.; Renz, B.; Niess, H.; Hammad, S.; Holstein, E.; Danielczyk, L.; Liebe, R.; Weng, H.; Klingmueller, U.; Ebert, M. P. A.; Gao, C.; Bode, J.; Inverso, D.; ten Dijke, P.; Wang, S.; Hoehme, S.; Fan, W.; Dooley, S.; Wang, S.
Show abstract
Hepatocyte growth factor (HGF) is a multifunctional cytokine stored in the extracellular matrix as an inactive precursor and is essential for tissue repair. How HGF activity is dynamically regulated during regeneration remains unclear. Here, we identify extracellular matrix protein 1 (ECM1) as a physiological inhibitor of active HGF during liver regeneration. Following 70% partial hepatectomy, active HGF rapidly increases in parallel with a sharp decline in ECM1, and preventing this downregulation delays liver mass recovery. Mechanistically, ECM1 directly binds the active HGF -subunit through a mechanism dependent on residue R392, thereby suppressing c-MET-ERK-MYC signaling and hepatocyte proliferation. Loss of ECM1 permits activation of this pathway, whereas MYC overexpression rescues ECM1-mediated growth inhibition. In patients, proliferative hepatocytes localize to ECM1-negative regions. Supported by transcriptomic analyses and computational modeling, these findings identify ECM1 as an extracellular gatekeeper whose transient downregulation enables HGF-driven tissue repair. HighlightsO_LIECM1 is temporally downregulated during liver regeneration, while forced ECM1 expression delays liver mass recovery after 70% PHx by suppressing hepatocyte proliferation. C_LIO_LIRapid and transient ECM1 downregulation permits HGF-c-Met-ERK-MYC signaling to drive hepatocyte cell-cycle entry and expansion. C_LIO_LIECM1 directly binds the active HGF -subunit with residue R392 playing a critical role, revealing a novel extracellular mechanism for growth factor inhibition. C_LIO_LILoss of ECM1 marks proliferative hepatocytes in human liver repair, identifying ECM1 as a tunable regulator of regenerative capacity. C_LI
Matching journals
The top 11 journals account for 50% of the predicted probability mass.